[ad_1] Curis Lifesciences, which posted over 75 per cent jump in revenue in the first half of 2025-26, expects a higher growth in exports to the Middle East and Africa in the next financial year, a top company official said on Friday. The company backed by noted investor Mukul Agrawal expects steady growth next fiscal…
[ad_1] Ipca Laboratories on Friday said the US health regulator has issued a Form 483 with three observations after inspecting its Maharashtra-based API plant. The US Food and Drug Administration (USFDA) conducted the inspection of the active pharmaceutical ingredients (APIs) manufacturing facility at Tarapur (Maharashtra) from December 1-5, 2025. At the conclusion of the inspection,…
[ad_1] The Union Commerce ministry has told a parliamentary panel that fresh US tariffs on pharmaceutical imports are unlikely to significantly hit India, as the country primarily exports generic drugs rather than patented ones that are more affected by the decision, The Times of India reported on September 30. At a meeting of the Public…